Latest Articles
Endometriosis: Why it takes an average of 8 Years to diagnose — and how to get answers faster - FemTech World
Endometriosis: Why it takes an average of 8 Years to diagnose — and how to get answers faster FemTech World
Published: April 10, 2026, noon
New AI femtech competition in Portugal aims to fast-track women’s health innovation - Tech.eu
New AI femtech competition in Portugal aims to fast-track women’s health innovation Tech.eu
Published: April 10, 2026, 8:38 a.m.
New NHS pathways aims to speed up endometriosis diagnosis and treatment - FemTech World
New NHS pathways aims to speed up endometriosis diagnosis and treatment FemTech World
Published: April 9, 2026, 8:06 a.m.
Proseek Bio raises AU$1.5m for ovarian cancer blood test - FemTech World
Proseek Bio raises AU$1.5m for ovarian cancer blood test FemTech World
Published: April 8, 2026, 11 a.m.
Proseek Bio raises AU$1.5m for ovarian cancer blood test - femtechworld.co.uk
Proseek Bio raises AU$1.5m for ovarian cancer blood test femtechworld.co.uk
Published: April 8, 2026, 11 a.m.
NICE issues fertility guidance for people with endometriosis - FemTech World
NICE issues fertility guidance for people with endometriosis FemTech World
Published: April 7, 2026, 11:05 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - femtechinsider.com
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com
Published: April 1, 2026, 11:54 a.m.
Report reveals what women’s health innovators get wrong about coverage - FemTech World
Report reveals what women’s health innovators get wrong about coverage FemTech World
Published: March 31, 2026, 11 a.m.
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: March 30, 2026, 1:56 p.m.
Link copied to clipboard!